Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Contemporary Clinical Trials Communications Year : 2008

Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial

Abstract

The aim of phase II single-arm clinical trials of a new drug is to determine whether it has sufficient promising activity to warrant its further development. For the last several years Bayesian statistical methods have been proposed and used. Bayesian approaches are ideal for earlier phase trials as they take into account information that accrues during a trial. Predictive probabilities are then updated and so become more accurate as the trial progresses. Suitable priors can act as pseudo samples, which make small sample clinical trials more informative. Thus patients have better chances to receive better treatments. The goal of this paper is to provide a tutorial for statisticians who use Bayesian methods for the first time or investigators who have some statistical background. In addition, real data from three clinical trials are presented as examples to illustrate how to conduct a Bayesian approach for phase II single-arm clinical trials with binary outcomes.
Fichier principal
Vignette du fichier
PhaseII_single_arm_HAL.pdf (1.08 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-02456790 , version 1 (28-01-2020)

Identifiers

Cite

Sarah Zohar, Satoshi Teramukai, Yinghui Zhou. Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial. Contemporary Clinical Trials Communications, 2008, 29 (4), pp.608-616. ⟨10.1016/j.cct.2007.11.005⟩. ⟨inserm-02456790⟩

Collections

INSERM UNIV-PARIS7
205 View
525 Download

Altmetric

Share

Gmail Facebook X LinkedIn More